GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus

Danying Chena Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Zhifei Houa Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of China;c Department of Pulmonary and Critical Care Medicine, General Hospital of Datong Coal Mine Group Co., Ltd., People’s Republic of ChinaView further author information

Dong Jianga Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Mei Zhenga Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Guoli Lia Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Yue Zhanga Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Rui Lia Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Hanxin Lind Department of Pathology and Laboratory Medicine, Western University, London, Ontario, CanadaView further author information

Jinhong Change Baruch S. Blumberg Institute, Hepatitis B Foundation, Doylestown, PA, USAView further author information

Hui Zenga Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaView further author information

Ju-Tao Guoe Baruch S. Blumberg Institute, Hepatitis B Foundation, Doylestown, PA, USACorrespondence[email protected]
View further author information

Xuesen Zhaoa Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China;b Beijing Key Laboratory of Emerging Infectious Disease, Beijing, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0003-1286-5733 View further author information

show all

GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus

Articles from other publishers (22)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus

Citations (22)

Articles from other publishers (22)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date